Scandion Oncology (Sweden) Price Prediction
| SCOL Stock | SEK 0.07 0 5.63% |
Oversold Vs Overbought
34
Oversold | Overbought |
Using Scandion Oncology hype-based prediction, you can estimate the value of Scandion Oncology AS from the perspective of Scandion Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Scandion Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Scandion because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Scandion Oncology after-hype prediction price | SEK 0.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Scandion |
Scandion Oncology After-Hype Price Prediction Density Analysis
As far as predicting the price of Scandion Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Scandion Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Scandion Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Scandion Oncology Estimiated After-Hype Price Volatility
In the context of predicting Scandion Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Scandion Oncology's historical news coverage. Scandion Oncology's after-hype downside and upside margins for the prediction period are 0.00 and 5.30, respectively. We have considered Scandion Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Scandion Oncology is out of control at this time. Analysis and calculation of next after-hype price of Scandion Oncology is based on 3 months time horizon.
Scandion Oncology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Scandion Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Scandion Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Scandion Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.91 | 5.22 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.07 | 0.08 | 6.67 |
|
Scandion Oncology Hype Timeline
Scandion Oncology is at this time traded for 0.07on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Scandion is anticipated to increase in value after the next headline, with the price projected to jump to 0.08 or above. The average volatility of media hype impact on the company the price is insignificant. The price appreciation on the next news is anticipated to be 6.67%, whereas the daily expected return is at this time at -0.91%. The volatility of related hype on Scandion Oncology is about 0.0%, with the expected price after the next announcement by competition of 0.08. Assuming the 90 days trading horizon the next anticipated press release will be within a week. Check out Scandion Oncology Basic Forecasting Models to cross-verify your projections.Scandion Oncology Related Hype Analysis
Having access to credible news sources related to Scandion Oncology's direct competition is more important than ever and may enhance your ability to predict Scandion Oncology's future price movements. Getting to know how Scandion Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Scandion Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HNSA | Hansa Biopharma AB | 0.00 | 0 per month | 0.00 | (0.26) | 3.40 | (5.68) | 21.12 | |
| SANION | Saniona AB | 0.00 | 0 per month | 6.33 | 0.10 | 17.14 | (7.01) | 72.42 | |
| ONCO | Oncopeptides AB | 0.00 | 0 per month | 0.00 | (0.12) | 3.83 | (3.69) | 34.67 |
Scandion Oncology Additional Predictive Modules
Most predictive techniques to examine Scandion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Scandion using various technical indicators. When you analyze Scandion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Scandion Oncology Predictive Indicators
The successful prediction of Scandion Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Scandion Oncology AS, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Scandion Oncology based on analysis of Scandion Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Scandion Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Scandion Oncology's related companies.
Story Coverage note for Scandion Oncology
The number of cover stories for Scandion Oncology depends on current market conditions and Scandion Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Scandion Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Scandion Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Scandion Oncology Short Properties
Scandion Oncology's future price predictability will typically decrease when Scandion Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Scandion Oncology AS often depends not only on the future outlook of the potential Scandion Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Scandion Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.6 M | |
| Cash And Short Term Investments | 105.7 M |
Additional Tools for Scandion Stock Analysis
When running Scandion Oncology's price analysis, check to measure Scandion Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandion Oncology is operating at the current time. Most of Scandion Oncology's value examination focuses on studying past and present price action to predict the probability of Scandion Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandion Oncology's price. Additionally, you may evaluate how the addition of Scandion Oncology to your portfolios can decrease your overall portfolio volatility.